beta-solamarine has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY; Tsai, EM | 1 |
| Chang, LC; Huang, YS; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY | 1 |
| Huang, YS; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY | 1 |
3 other study(ies) available for beta-solamarine and Breast Neoplasms
| Article | Year |
|---|---|
Solamargine induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/neu.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Epirubicin; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Solanaceous Alkaloids; Trastuzumab | 2009 |
Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cisplatin; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Enzymologic; Humans; Inhibitory Concentration 50; Signal Transduction; Solanaceous Alkaloids; Up-Regulation | 2007 |
Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu.
Topics: Antineoplastic Agents; Blotting, Southern; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Radioimmunoassay; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; Solanaceous Alkaloids | 2008 |